!MN中国临床康复第!"卷第#$期!""#$"#$!%!"
!"#$%&%’()*$+,(-!,#$#.+,/%"+0#,#1+1#($2’)$%3435567(,895:(83;
ABCD!/ECEB/!F :CC$)*%"C(-$*1#DC-0$#1’(-’"%-*"BE$F1&E"%&E1*$"’*E$"’%$*"C)1#)-’"G1"CB1#H$-’*$%*-’$-’#1*%-’(I)$(0D
JKLM(-G$*EDBED(#1N-’$!
%&’()*’(!+,-*’(.*/01/’(#+,-*’(,-2’(3+4-2’5/’(06/’(!
’()*+,-(.,/012,+3,3/.*.45//46783(.(96*+:3.;(43<*=>.3?(+@3,79
6*+:3.&#&"""96(3=/.8A3*.8B+/?3.<(9CD3.*E!’()*+,-(.,/012,+3,3/.9
F3.84*/;2.3<3)*=6/@)3,*=9F3.84*/!##"&&9GD*.4/.8B+/?3.<(9CD3H
.*EI’()*+,-(.,/0J3/<D(-3@,+79;(43<*=C/==(8(9F3.84*/>.3?(+@3,79
F3.84*/!##"!&9GD*.4/.8B+/?3.<(9CD3.*
%&’()*’(!9G,2473.80/+4/<,/+*,(9B+/0(@@/+9’()*+,-(.,/012,+3,3/.
*.45//46783(.(96*+:3.;(43<*=>.3?(+@3,796*+:3.&#&"""96(3H
=/.8A3*.8B+/?3.<(9CD3.*
!"##$%&"’($’)$*"+4-2’5/’(06/’(9B+/0(@@/+9’()*+,-(.,/012,+3,3/.
*.45//46783(.(96*+:3.;(43<*=>.3?(+@3,796*+:3.&#&"""96(3H
=/.8A3*.8B+/?3.<(9CD3.*&(<+(*@(4*@</-)*+(4P3,D,D(</.,+/=8+/2)^(M&QL‘MQK)X,LIQ#‘!Qb)X,(##QK‘KQL)X,<a"Q"&*.4"Q"%cQ!57!@6><57+O,-*73.<+(*@(,D(3.<34(.<(+*,(/0<*+<3./-*/0=*+8(3.,(@,3.(PD(.)(<,3.3@*44(43.43(,9/.,D(</.,+*+79,D(+*,(4(<+(*@(@303./@3,/=D(T*)D/)D*,(3@*44(43.,D(P*,(+Q%&’()+,-*’(.7+,-*’(,+4-2’589:;;2<=>&;?/2=*@A;/B2@*’?/’&>/=&C-2D*1-&>1-*=2&’=-2&’>2=&;<*@</’&E*&;C*@(2/’=2>=/’2/’@*=>/’?F<2?BA!+#0?/E2=-AC-A?@*G/’29="($>>)(?#$.")+$>@+$>-)#""HI!"J#$KL!MNON!J4-/’*KPQQQ9G(C<R;9<&ES
,$)$-.$(+!""%$&"$"K/))$&*$(+!""#$"!$&"("%$%"$L$#!%MNG)
/0%*#1)*
2/!34,5678+O.<34(.<(+*,(/0<*+<3./-*/0=*+8(3.,(@,3.(3.<+(*@(@
P3,D,D(4(?(=/)-(.,/0.*,3/.*==3?3.8@,*.4*+4Q;*.7()34(-3/=/83<@2+H
?(7@D*?(@D/P(4,D*,43(,*+70*<,/+@D*?(<=/@(=7</++(=*,3/.P3,DD38D
+3@R/0<*+<3./-*/0=*+8(3.,(@,3.(Q
529:!;<=:+S//:@(+?(,D((00(<,/043(,*+703:(+*.43./@3,/=
D(T*)D/@)D*,(/.,D(3.<34(.<(/0<*+<3./-*/0=*+8(3.,(@,3.(:7(@,*:H
=3@D3.8+*,-/4(=@P3,D<*+<3./-*/0=*+8(3.,(@,3.(Q
8:><47+U*.4/-3V(4:=/<R4(@38.Q
>:;;<74+O.@,3,2,(/012,+3/=/879;(43<*=C/==(8(9F3.84*/>.3?(+@3,7Q
?/;:,</@>+SD((T)(+3-(.,P*@)(+0/+-(4*,,D(O.@,3,2,(/012,+3/=H
/879;(43<*=C/==(8(9F3.84*/>.3?(+@3,70+/-;*+<D,/’(<(-:(+!""MQ
S/,*==7L#-*=(W3@,*++*,@/0MP((R@P(+(+*.4/-=7*@@38.(4:*@(4/.
:/47-*@@3.,/<(==2=/@(8+/2)P3,D&M+*,@9)(<,3.8+/2)P3,D&M+*,@93.H
/@3,/=D(T*)D/@)D*,(8+/2)P3,D&%+*,@9<(==2=/@()=2@3./@3,/=D(T*)D/@H
)D*,(8+/2)P3,D&M+*,@9)(<,3.)=2@3./@3,/=D(T*)D/@)D*,(8+/2)P3,D&M
+*,@*.4</.,+/=8+/2)P3,D&%+*,@Q
?:;A58>+J*@3<0((4P3,D/2,43(,*+703:(+P*@83?(.3.,D(</.,+/=
8+/2)Q&"X)(<,3.P*@*44(43.,D()(<,3.8+/2)Q&"X<(==2=/@(P*@
*44(43.,D(<(==2=/@(8+/2)Q!X@/432-)D7,*,(P*@*44(43.,D(P*,(+/0
3./@3,/=D(T*)D/@)D*,(8+/2)Q&"X)(<,3.*.4!X@/432-)D7,*,(P(+(
*44(43.,D(P*,(+/0)(<,3.)=2@3./@3,/=D(T*)D/@)D*,(8+/2)Q&"X<(==2H
=/@(*.4!X@/432-)D7,*,(4+3.R3.8P*,(+P(+(*44(43.,D(<(==2=/@(
)=2@3./@3,/=D(T*)D/@)D*,(8+/2)QY,/,*=/0L#+*,@+(<(3?(4&9!H43-(,D7=H
D74+*V3.(Z’;6[:7@2:<2,*.(/2@3.A(<,3/.,/3.42<(<*+<3./-*/0=*+8(
3.,(@,3.(*,P((RM*0,(+:+((43.8QO.<34(.<(+*,(/0=*+8(:/P(=.(/)=*@-9
.2-:(+*.4?/=2-(/0,2-/+P(+(/:@(+?(4QB+/=30(+*,3.8*<,3?3,7/0=*+8(
3.,(@,3.*=-2</@*<(==@P*@4(,(+-3.(4Z,D(+*,3//0.2-:(+/0)/@3,3?(
<(==@/0)+/=30(+*,3.8<(==.2<=(*+*.,38(.,/,/,*=</2.,/0.2<=(2@[Q
?/<756;!5?:?:/>6,:>+!O.<34(.<(+*,(/0=*+8(:/P(=.(/H
)=*@-3.(*<D8+/2)9<D*.8(@/0-(*..2-:(+*.4-(*.?/=2-(/0,2-/+@
/0(*<D+*,9*.4")+/=30(+*,3.8*<,3?3,7/0=*+8(3.,(@,3.*=-2</@*<(==@/0
+*,@Q
,:>6@;>+!;/@,/0,D(+*,@3.(*<D8+/2)43(442+3.8,D(!"HP((R,+3H
*=Q\.(+*,43(43.,D()(<,3.8+/2)9,D()(<,3.)=2@3./@3,/=D(T*)D/@)D*,(
8+/2)*.4,D(</.,+/=8+/2)9+(@)(<,3?(=7*0,(+!"P((R@Q"SD(+(P*@./
@38.303<*.,4300(+(.<(3.,D(3.<34(.<(+*,(/0=*+8(:/P(=.(/)=*@-/0+*,@
</-)*+(4P3,D,D(</.,+/=8+/2)(<]"Q"%)9:2,,D(-(*..2-:(+*.4
-(*.?/=2-(/0,2-/+@/0(*<D+*,3.,D(3./@3,/=D(T*)D/@)D*,(8+/2)
(,P(+(@38.303<*.,=7=/P(+,D*.,D/@(3.,D(</.,+/=8+/2)^_2*.,3,7:&Q&‘"Q!)
I((,(MQ&‘&Q!)+*,@,<a"Q"&;?/=2-(:&K#Q&‘#%Q%)&"M#QK‘M#bQ")--,
<a"Q"%c9*.4,D(-(*..2-:(+/0,2-/+@/0(*<D+*,3.,D()(<,3.
)=2@3./@3,/=D(T*)D/@)D*,(8+/2)P*@/:?3/2@=7D38D(+,D*.,D*,3.,D(
,(</.,+/=8+/2)^(KQ%‘&Qb)KQ!‘&Q")+*,@,<a"Q"%cQ#SD()+/=30(+*,3.8
*<,3?3,7/0=*+8(3.,(@,3.*=-2</@*<(==@3.,D(3./@3,/=D(T*)D/@)D*,(
8+/2)@38.303<*.,=74(<+(*@(4*@</-)*+(4P3,D,D(</.,+/=8+/2)QSD(
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bK&^&cQG/0*+,D(+()/+,@P(+(4300(+(.,*,D/-(*.4*:+/*49@/-((?(.D(=4/))/@3,(</.<=2@3/.Qd+*0%1+,^!c0/2.4,D*,,D(+(P*@,D(@*-(43H(,*+703:(+3.’*.(*.453..@9:2,,D(3.<34(.<(+*,(/0<*+<3./-*/0=*+8(3.,(@,3.(3.’*.(P*@8+(*,=7D38D(+,D*.,D*,3.53..@3.,D(*.*=7@3@/0</++(=*,3/.:(,P((.43(,*+7*.4,D(/.@(,/0<*+<3H./-*/0=*+8(3.,(@,3.(QO.8(@,(443(,/053..@</.,*3.(4-*+R(4=7D38D(+3./@3,/=D(T*)D/@)D*,(*@</-)*+(4P3,D,D(’*.(9,D(+(H0/+(93,P*@</.<=24(4,D*,/.=743(,*+703:(+P3,D+3<D3./@3,/=D(T*)D/@)D*,(</2=4)+(?(.,<*.<(+Q&,!H43-(,D7=D74+*V3.(Z’;6[P*@2@(43.,D(,+3*=,/3.42<(W3@,*++*,-/4(=@P3,D<*+H<3./-*/0=*+8(3.,(@,3.(Q’300(+(.,</-)/.(.,/043(,*+703:(+*.4?*+3/2@(00(<,/03./@3,/=D(T*)D/@)D*,(3.3.,(@,3.*=,+*<,P(+(3.H@)(<,(43.,D(D/)(/03.@,+2<,3.8+*,3/.*=43(,*.4)+(?(.,3.8,D(/<<2++(.<(/0<*+<3./-*/0=*+8(3.,(@,3.(Q?/;:,</@>/78?:;A58>?1*$#-1B%SD((T)(+3-(.,P*@</.42<,(4*,,D(O.@,3,2,(/012,+3/=/879;(4H3<*=C/==(8(9F3.84*/>.3?(+@3,7:(,P((.;*+<D*.4’(<(-:(+!""MQeT)(+3-(.,*=*.3-*=@*.4*.3-*=0((4@f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
膳食纤维与肌醇六磷酸对1,2-二甲肼诱导大鼠大肠癌发生的作用_医药卫生_专业资料。膳食纤维!"# 中国临床康复 第 !" 卷第 #$ 期 !""#$"#$!% !" !"#...
目的探讨健脾康复丸对二甲基肼(DMH)诱导的大鼠大肠癌的预防作用。方法用1,2-二甲基肼腹腔注射诱导大鼠发生大肠癌,观察健脾康复丸对诱癌率及胸腺指数和脾指数等的...
二甲肼诱发大鼠大肠癌癌前病变模型的肠道双歧杆菌数量研究_专业资料。目的:探讨二甲肼(DMH)诱发的大肠癌癌前病变模型大鼠的肠道内双歧杆菌数量与大肠癌癌前病变的...
膳食纤维的功能 3.1促进酵解,防治结肠癌H¨“12....可提高大鼠的糖耐 量,从而降低糖尿病的发生.王子花...由于膳食纤维可能会降低血液中诱导乳腺癌 的雌性激素...
包括 蜡质、肌醇六磷酸、角质、皂角苷、软木脂和单...7.3膳食纤维的功能作用 1膳食纤维的特性(1)具有...横隔膜症 及痔疮等肠道疾病,降低了肠癌的发病率。 ...
大肠癌综述 (大肠恶性肿瘤、结肠癌、直肠癌) [概述...Reddy 等 用二甲肼(DMH)诱发大鼠大肠肿瘤,在含 5...分析营养素与结、 直肠癌的关系发现膳食纤维起着...
2.吸附作用膳食纤维分子表面带有很多活性基因, 可以...纤维排出体外,这是 膳食纤维能预防结肠癌的重要原因...其原因是麦豉中含有大量的肌醇六磷酸,这是一种抗 ...
Reddy 等用二甲肼(DMH)诱发大鼠大肠肿瘤,在含 5%...直 肠癌的关系发现膳食纤维起着重要的保护性作用;而...左半结肠 癌为 2.1 倍,右半结肠癌为 1.8 倍...
膳食纤维的作用机制可能为: ( 1) 膳食纤维影响食物...常银子等〔3〕证明百合膳食纤维对大鼠具有降血脂 和...清除活性的物质可能是膳食纤维能防治结肠癌的重要原因...
2 膳食纤维的特性 2.1 吸水作用膳食纤维有很强的...通过临床实验和调查研究发现,膳食 纤维防治结肠癌机理...3.4 对胃肠道粘膜的保护作用有通过对大鼠研究结果...
热门文档